The screening and management of newborns at risk for low blood glucose

Michael R Narvey1, Seth D Marks1

  • 1Canadian Paediatric Society, Fetus and Newborn Committee, Ottawa, Ontario.

Paediatrics & Child Health
|December 18, 2019
PubMed

Insights

Newborn hypoglycemia is common, but updated guidelines help identify and manage infants at risk. Protocols now better address transitional and persistent hypoglycemia, including dextrose gel use.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology

Background:

  • Hypoglycemia is a frequent condition in newborns, with some cases representing normal adaptation and others indicating prolonged issues.
  • Effective management is crucial for neonatal health outcomes.

Purpose of the Study:

  • To provide updated guidance on defining, identifying, and managing neonatal hypoglycemia.
  • To outline revised screening, monitoring, and intervention protocols for at-risk infants.
  • To address the use of dextrose gels and post-discharge care strategies.

Main Methods:

  • Review and revision of existing protocols for neonatal hypoglycemia management.
  • Differentiation of care strategies for transitional (first 72 hours) versus persistent hypoglycemia.
  • Inclusion of evidence-based recommendations for dextrose gel therapy and recurrence prevention.

Main Results:

  • Revised protocols aim to improve the identification, management, and treatment of infants with persistent, recurrent, or severe hypoglycemia.
  • Dextrose gels are discussed as a potential intervention to increase glucose levels or prevent prolonged hypoglycemia.
  • Clear distinctions are made between managing hypoglycemia in the early transitional phase and later persistent cases.

Conclusions:

  • Updated guidelines offer a refined approach to neonatal hypoglycemia care.
  • The revised protocols emphasize early identification and tailored interventions for better infant outcomes.
  • Emphasis is placed on managing both short-term transitional hypoglycemia and longer-term persistent forms.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
747
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.0K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K